Cell Therapy Bioprocessing
Dr. Peter Zandstra, Professor of Stem Cell Bioengineering, University of Toronto
Dr. Robert Deans, Vice President of Regenerative Medicine, Athersys Inc.
Tuesday February 8, 2011 11AM-12:30PM EST
SBE Webinars are free for SBE members and $49 for non-members. For registration issues, please contact Arjun Gopalratnam at arjug@aiche.org. You will receive a receipt upon registration and a login link in your email on the day of the webinar. Please make sure that the email address listed in your SBE profile will be accessible on the day of the webinar.
Webinars are conducted through WebEx. You may wish to Test WebEx on your computer. Please contact Customer Services at custserv@aiche.org or call 800-242-4363 (203-702-7660 outside the US) for assistance.
About the Webinar
As cellular therapies are advancing through clinical development and getting closer to market, close collaborations between stem cell biologists, clinical cell processing technologists, and bioengineers will be required for effective commercialization of this new class of drugs. New cell production strategies and technologies will be needed to supply sufficient quantities of cells, of pre-defined quality and biological functionality, and at reasonable costs as these new products come to market. Just as protein therapeutics went through a technology transformation during the 1990’s, cell therapy bioprocessing technologies will go through a similar standardization and scalability evolution over the next 5-15 years. This Webinar will outline many of the challenges and opportunities that lie before the Cell Therapy industry as it transforms from a niche market industry to blockbuster drug status, with a real-world example of a cell therapy drug in mid-stage clinical development.
Please join us as this new industry evolves, and as the technical discipline of Cell Therapy Bioprocesing is emerging.
This webinar is prsented by the International Society for Cellular Therapy and the Society for Biological Engineering.
